Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32results about How to "Maintain specificity" patented technology

Anti-human hepatoma monoclonal antibody hav18 light/heavy chain available region gene, and use thereof

The present invention relates to the anti-human hepatocarcinoma McAb HAb18 heavy chain and light chain variable region genes, the polypeptides encoded by the same, as well as to their use in the preparation of a medicament for diagnosing and treating tumors or inflammation diseases. Based on the heavy chain and light chain variable region genes, various novel small molecule genetic engineering antibodies, including single chain antibodies, chimeric antibodies, Fab antibodies and the like can be constructed and expressed for the diagnosis and treatment of hepatoma.
Owner:CHEN ZHINAN +2

Methods and compositions for multivalent binding and methods for manufacture of rapid diagnostic tests

The invention provides reagents and methods for multivalent binding and quantitative capture of components in a sample. In one aspect, reagents and methods for diagnostic assay for antigen, ligand, binding agent, or antibody are provided. Compositions of a non-natural or deliberately constructed nucleic acid-like polymeric scaffold are provided, to which multiple antibodies, peptides or other binding agents can be affixed by hybridization of a oligonucleotide: binding agent complex such that the nucleic acid: binding agent construction displays multivalent behavior when interacting with a multivalent analyte. Methods for constructing and using the scaffolds are described. Such compositions may include assembly of mixed specificity binding agents such that the composition displays multivalent binding behavior against a target containing mixed analytes which can be bound by the construct to effect a binding affinity increase such as is observed in avidity reagents against single analytes expressed multiply on the target analyte. A manufacturing method for producing rapid diagnostic assays in a decentralized manner is also described. The method generates net economic advantages over conventional diagnostic manufacturing practices.
Owner:LANE MICHAEL J +2

Protection of barcodes during DNA amplification using molecular hairpins

Described herein are approaches for the improved detection, identification, and / or quantification of target nucleic acids. These approaches provide a means of detecting, identifying, and / or quantifying rare target nucleic acid molecules, including DNA and RNA molecules, from the same sample, and in the same reaction, by using “hairpin barcode primers,” as the term is defined herein, to incorporate unique barcodes into target nucleic acids in a PCR pre-amplification step.
Owner:ONTARIO INST FOR CANCER RES OICR +1

Kir3dl2 binding agents

The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same.
Owner:INNATE PHARMA SA

Device and method for detection and identification of immunological proteins, pathogenic and microbial agents and cells

The present invention provides a method and device for detecting and quantifying the concentration of magnetic-responsive micro-beads dispersed in a liquid sample. Also provided is a method and microfluidic immunoassay pScreen™ device for detecting and quantifying the concentration of an analyte in a sample medium by using antigen-specific antibody-coated magnetic-responsive micro-beads. The methods and devices of the present invention have broad applications for point-of-care diagnostics by allowing quantification of a large variety of analytes, such as proteins, protein fragments, antigens, antibodies, antibody fragments, peptides, RNA, RNA fragments, functionalized magnetic micro-beads specific to CD4+, CD8+ cells, malaria-infected red blood cells, cancer cells, cancer biomarkers such as prostate specific antigen and other cancer biomarkers, viruses, bacteria, and other pathogenic agents, with the sensitivity, specificity and accuracy of bench-top laboratory-based assays.
Owner:CARNEGIE MELLON UNIV

Devices and Methods for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells

The present invention provides a method and microfluidic immunoassay pScreen™ device for detecting and quantifying the concentration of an analyte in a liquid sample by using antigen-specific antibody-coated magnetic-responsive micro-beads. The methods and devices of the present invention have broad applications for point-of-care diagnostics by allowing quantification of a large variety of analytes, such as proteins, protein fragments, antigens, antibodies, antibody fragments, peptides, RNA, RNA fragments, functionalized magnetic micro-beads specific to CD4+, CD8+ cells, malaria-infected red blood cells, cancer cells, cancer biomarkers such as prostate specific antigen and other cancer biomarkers, viruses, bacteria, and other pathogenic agents, with the sensitivity, specificity and accuracy of bench-top laboratory-based assays.
Owner:CARNEGIE MELLON UNIV

Devices and Methods for Detection and Quantification of Immunological Proteins, Pathogenic and Microbial Agents and Cells

The present invention provides microfluidic pScreen™ devices for quantifying the concentration of DNA fragments in a liquid sample by using magnetic-responsive silica micro-beads and nonmagnetic-responsive silica micro-beads. The devices of the present invention allow for rapid, simple and inexpensive quantification of DNA fragment concentration in a sample. The devices do not require complex instrumentation and can be performed in less than three minutes. Moreover, they are compatible with complex samples including, without limitation, unpurified PCR amplification products, and thus can be expected to seamlessly integrate into various common molecular biology techniques and workflows.
Owner:CARNEGIE MELLON UNIV

Rice sucrose tranporter gene promoter

The present invention provides DNA having the promoter activity of an OsSUT1 gene, as well as a transgenic plant and others capable of expressing a desired foreign gene specifically in the vascular bundle or the phloem thereof, using the above DNA as a promoter. According to the present invention, DNA having the promoter activity of the OsSUT1 gene was isolated from the genomic library of rice (Oryza sativa L.) The DNA has a promoter sequence, which has a phloem specificity and a growing time specificity and exists in a nucleotide sequence shown in SEQ ID NO: 1. A transgenic plant expressing a foreign gene specifically in the phloem or in the vascular bundle system tissues was produced by ligating the desired foreign gene downstream of the promoter DNA and incorporating it into the genome of a plant.
Owner:SYNGENTA LTD

Kir3dl2 binding agents

The present invention relates to methods for the treatment of cancer and inflammatory disease using antibodies (e.g. monoclonal antibodies), antibody fragments, and derivatives thereof that specifically bind KIR3DL2. The invention also relates to antibodies, cells producing such antibodies; methods of making such antibodies; fragments, variants, and derivatives of the antibodies; pharmaceutical compositions comprising the same.
Owner:INNATE PHARMA SA

Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets

The invention provides cells and methods for identifying modulators of signal transduction, based on transducisome proteins that coordinate and assemble many types of signal transduction proteins. A transducisome is a PDZ domain containing protein that binds at least one signal transduction protein or a PDZ domain containing protein with at least one signal transduction protein bound. Examples of transducisome proteins include INAD, GRIP and other recently identified multi-PDZ domain proteins. Examples of signal transduction proteins include GPCRs, tyrosine kinase receptors, tyrosine phosphatase receptors, ion channels, phospholipases, adenylate cyclases, kinases and G-proteins. Also provided are methods for identifying modulators of signal transduction, proteins (and polynucleotides encoding the same) corresponding to transducisomes, modified transducisomes or defective transducisomes to use in assays of signal transduction, and a screening assay system for detecting protein-protein interactions.
Owner:VERTEX PHARMA SAN DIEGO LLC

Tissue culture and rapid propagation method for variation malus spectabilis

The invention discloses a tissue culture and rapid propagation method for variation malus spectabilis, and belongs to the field of plant tissue culture and propagation. The tissue culture and rapid propagation method has the advantages that processes for explant selection and disinfection, primary culture, secondary culture, rooting culture, transplanting and the like in variation malus spectabilis tissue culture are provided, accordingly, the contamination rate of the variation malus spectabilis tissue culture and the death rate of tissue culture seedlings due to improper handling can be reduced, and the variation malus spectabilis tissue culture efficiency can be improved.
Owner:JIANGSU UNIV

Peptide nucleic acid conjugates

The present disclosure is directed to conjugates of a specific binding entity and an oligomer, i.e. [Specific Binding Entity]-[Oligomer]n, wherein n is an integer ranging from 1 to 12, and where the Oligomer includes, in some embodiments, a PNA sequence having at least one substituent at a gamma carbon position. In some embodiments, the substituent at the gamma carbon position, e.g. an amino acid, a peptide, a miniPEG, or a polymer, includes at least one reporter moiety.
Owner:VENTANA MEDICAL SYST INC

Repeat-chain for the production of dimer, multimer, multimer complex and super-complex

The present invention relates to a method for manufacturing multimers by making repeat-chains comprising repeatedly linked affinity domains binding specifically to monomers, and by using the same to create a repeat-chain / multiple-monomer complex created from the repeat-chains and a multiple number of monomers, thereby facilitating the formation of bond bridges between the monomers in the complex to produce inter-monomeric bond bridged multimer.The present invention relates to a super-complex prepared by cross-binding between repeat-chain / multiple-monomer complexes, and a method for amplifying the effect of monomer through the formation of the said super-complex. Particularly, the repeat-chain / multiple-monomer complex is prepared by containing repeat-chains of binding domain having binding specificity to monomers as active ingredients, and then the super-complex is prepared by cross-binding between such complexes.
Owner:MUHYEON CHOE

Method for the quantification of faecalibacterium prausnitzii phylogroup i and/or phylogroup ii members and the use thereof as biomarkers

ActiveUS20190024146A1Preserve specificityBroad coverageMicrobiological testing/measurementICT adaptationTherapeutic treatmentDrug
The present invention relates to a novel method for an accurate quantification in intestinal samples of Faecalibacterium prausnitzii phylogroup I members (PHGI) and / or Faecalibacterium prausnitzii phylogroup II members (PHGII). It further relates to a method for detecting intestinal diseases, including the screening, diagnosis, differential diagnosis, and / or monitoring of disease activity or progression in a human subject comprising determining the abundance of PHGI and / or PHGII in an intestinal sample from said subject. Moreover, it relates to a method for the prediction of the efficacy of a drug in the therapeutic treatment of an intestinal disease in a human subject comprising determining the abundance of PHGI and / or PHGII in an intestinal sample from said subject.
Owner:GOODGUT SL

Multimerized enhancer domains for cell-specific expression

The invention features an enhancer cassette and methods of its use. The enhancer cassette has the formula [X−Y]n, wherein each X is independently a cell type-specific enhancer element; Y is absent or is a mono or polynucleotide that has between one and thirty nucleotides; and n is an integer between five and fifty, inclusive.
Owner:THE MCLEAN HOSPITAL CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products